Stanford University
Showing 651-660 of 831 Results
-
Keri Brenner
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioKeri Brenner, MD, MPA is Clinical Associate Professor of Medicine at Stanford University. As a palliative care physician and psychiatrist, her clinical work includes inpatient palliative care consultations at Stanford. She was inspired to pursue palliative care after serving at Mother Teresa’s Home for the Dying in Kolkata, India on multiple occasions. Dr. Brenner’s scholarly interests and research focus on the psychological elements of palliative care, specifically psychodynamic and existential issues in patients with serious illness. Dr. Brenner completed her medical degree at Yale School of Medicine, where she received honors for her thesis on the phenomenology of suffering with terminal illness. She also has a Master in Public Administration from Harvard’s Kennedy School. Dr. Brenner completed adult psychiatry residency at Massachusetts General Hospital and palliative care fellowship at Harvard. She served on the University of Notre Dame Board of Trustees (2005-2008), and was awarded funding through Harvard’s Radcliffe Institute for Advanced Study (2019). In her personal life, Dr. Brenner enjoys the beautiful outdoors of Northern California with her husband and four young children.
-
Cort Breuer
Ph.D. Student in Immunology, admitted Autumn 2022
BioCort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.
